Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 260-252-4 | CAS number: 56539-66-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1976
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 976
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to
- Guideline:
- OECD Guideline 412 (Subacute Inhalation Toxicity: 28-Day Study)
- Deviations:
- yes
- Remarks:
- Minimal reporting of test animals and husbandry, of test substance informations, of inhalation chamber, of exposure data and test conditions. It has not been tested on both sexes, just on male.
- Principles of method if other than guideline:
- test animals only male, no female /
by using a whole-body mode of exposure no deteails of animals’ breathing zone in an inhalation chamber /
minimal reporting of inhalation chamber - volume" of the test animals should not exceed 5% of the chamber volume /
for 6 hours per day on a 5 day per week basis for a period of 4 weeks / no details of housing conditions and feed of the test animals during the exposure time // no data about measured actual chamber concentration during exposure time /minimal reporting of exposure data - no data about nominal and actual concentrations from the test concentrations in the inhalation chamber
minimal reporting of test conditons
Test animals and husbandry - GLP compliance:
- no
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Details on test material:
- - Name of test material (as cited in study report): MMB
- Molecular formula (if other than submission substance):
- Molecular weight (if other than submission substance):
- Smiles notation (if other than submission substance):
- InChl (if other than submission substance):
- Structural formula attached as image file (if other than submission substance): see Fig.
- Substance type:
- Physical state: colorless and transparent liquid
- Analytical purity:
- Impurities (identity and concentrations):
- Composition of test material, percentage of components:
- Isomers composition:
- Purity test date:
- Lot/batch No.:
- Expiration date of the lot/batch:
- Radiochemical purity (if radiolabelling):
- Specific activity (if radiolabelling):
- Locations of the label (if radiolabelling):
- Expiration date of radiochemical substance (if radiolabelling):
- Stability under test conditions:
- Storage condition of test material:
- Other:
Test animals
- Species:
- rat
- Strain:
- other: JCL-SD
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 6 weeks
- Diet (e.g. ad libitum): Pellet chow CE-2 (CLEA Japan, Inc.) ad libitum
- Water (e.g. ad libitum): municipal tap water ad libitum
- Acclimation period: 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 0.5°C
- Humidity (%): 60 ± 5%
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- not specified
- Details on inhalation exposure:
- a total of 20 doses within 4 successive weeks.
- Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- none given
- Duration of treatment / exposure:
- 4 weeks
- Frequency of treatment:
- 4 hours/day, five times/week
Doses / concentrations
- Remarks:
- Doses / Concentrations:
100, 300, 500 ppm
Basis:
nominal conc.
- No. of animals per sex per dose:
- 10 (male)
- Control animals:
- yes
- Details on study design:
- Post-exposure period: None
- Positive control:
- none
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS and DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Observation including behavior and general condition was performed on all the
animals daily
BODY WEIGHT: Yes
- Time schedule for examinations: After the experiment initiation, body weight of all animals was determined before inhalation exposure at the rate of three times a week in the first two weeks (every other day), afterwards, twice a week (Tuesday and Friday). Moreover, weight gain index was calculated (the weight at the time of the experiment initiation is based to be 100).
WATER CONSUMPTION and FOOD CONSUMPTION:
- The total weight of each feeder and each water-supply bottle were measured every other day and the difference between last measurement value and latest measurement value was regarded as the daily food or water consumption.
OPHTHALMOSCOPIC EXAMINATION:No data
HAEMATOLOGY and CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: after completion of inhalation exposure experiments (for 20 times)
- Anaesthetic used for blood collection: Yes (pentobarbital sodium)
- Animals fasted: No data
- How many animals: all test animals and control animals
- Parameters checked in table [No. 1 - 4] were examined.
URINALYSIS: Yes
- The urine was collected at necropsy and the parameters listed below were examined using Multistix (Ames corporation).
Protein, Glucose, pH, Ketone, Bilirubin, Urobilinogen.
NECROPSY: Yes
- Macroscopical change was examined for thoracic cavity, organs in abdominal cavity at necropsy. Then, each organ was removed and the weight of the organs was measured. The ratio to the body weight (relative weight) was calculated using numerical
formula below.
Relative weight = organ weight / body weight x 100 (%)
NEUROBEHAVIOURAL EXAMINATION: No data
HISTOPATHOLOGICAL EXAMINATION:
- The following organs were collected from the animals immediately after the completion of necropsy, fixed in a neutral phosphate-buffered formalin solution and dehydrated to prepare 4 µm paraffin sections, and a microscopic examination was performed by hematoxylin eosin (HE) stain:
Liver, Kidney, Adrenal gland, Spleen, Heart, Lung, Brain and spinal cord, Testis - Sacrifice and pathology:
HISTOPATHOLOGY: Yes
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- No statistically significant changes
- Food consumption and compound intake (if feeding study):
- no effects observed
- Description (incidence and severity):
- No statistically significant changes
- Water consumption and compound intake (if drinking water study):
- no effects observed
- Description (incidence and severity):
- No statistically significant changes
- Haematological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- An increase of GOT in 100 and 500 ppm.
- Urinalysis findings:
- no effects observed
- Description (incidence and severity):
- No statistically significant change
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- Increases of absolute and relative weights of kidney in all treated groups
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- No effect related to the test material
- Details on results:
CLINICAL SIGNS AND MORTALITY
There were no atypical signs noted throughout the study in any animals.
BODY WEIGHT AND WEIGHT GAIN
All animals gained weight normally and neither delay of weight gain nor weight loss were noted during the study period. No significant difference from the control group was noted in any of the experimental group.
WATER CONSUMPTION and FOOD CONSUMPTION
In both food consumption and water consumption, no significant difference from the control group was noted in any of the experimental group.
HAEMATOLOGY and CLINICAL CHEMISTRY
The GOT activity in 500 ppm and 100 ppm exposure groups were significantly higher than that of control group (500 ppm exposure group was significantly different at p<0.05 (significance at 95% or above), 100 ppm exposure group was significantly different at p<0.01). In 500 ppm exposure group, one animal showed the remarkable high value of the GOT and GPT activity and one animal showed the remarkable high value of the GOT activity only. In other parameter, no significant difference from the control group was noted in any of the experimental group.
URINALYSIS
In all experimental parameter, no significant difference from the control group was noted in any of the experimental group.
ORGAN WEIGHTS
Although significantly higher values of absolute and relative kidney weights were observed in all experimental groups compared with control groups, there was no significant difference among three experimental groups. In other organs, no significant difference from the control group was noted in any of the experimental group.
NECROPSY
In many animals of all groups including control, slight congestion was observed in lung. (Often observed generally. Not the effect of MMB.) However no macroscopical abnormalities were noted in any other organs.
HISTOPATHOLOGY
Liver
Minute focal hepatic necrosis with slight cellular infiltration and/or debris of cell nucleus was noted in 1 animal of 500 ppm and 300 ppm exposure group, respectively, and in 2 animals of 100 ppm exposure group. It was seen in 1-2 places under the membrane and there was no MMB dose relationships in incidence of this finding. Nodule of round cell in sinusoid or Grisson's Capsule was noted in 6 animals of 500 ppm exposure group, in 7 animals of 300 ppm group, 9 animals of 100 ppm group and 9 animals of control group. This finding was considered to be the extramedullary hematopoiesis, therefore it is considered not to be pathological findings.
Kidney
The minute fibrosis of the cortex (just under the membrane) was noted in 2 animals in both of 500 ppm and 300 ppm exposure group, respectively, in 3 animals of 100 ppm exposure group and in 1 animal of the control group. In these areas, slight local fibrosis was noted and dilatation like cysts was also seen in renal tubule included in these area. The focal lymphocyte infiltration in stroma of the renal cortex (slight) was noted in 1 animal in both of 500 ppm and 300 ppm exposure group, respectively. On the other hands, slight lymphocyte infiltration was noted from mucous membrane of renal pelvis to medulla in 1 animal of the control group. However, glomerulus and uriniferous tubule showed no toxicologically relevant change.
Spleen
In many animals of all groups, congestion was noted. With the exception of congestion, no remarkable changes were noted.
Lung
In both of 500 ppm exposure group and control group, a few small hemorrhagic spots in lung parenchyma were noted in 1 animal, respectively.
Others
No remarkable abnormal findings were noted in testes, heart, adrenal gland, brain and spinal cord.
Effect levels
open allclose all
- Dose descriptor:
- LOAEC
- Effect level:
- 100 ppm
- Sex:
- male
- Dose descriptor:
- LOAEC
- Effect level:
- 530 mg/m³ air (nominal)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- other: based on 5.3 g/l vapour weight calculated from above
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Table 1: Hematological examination/Biochemical examination [500 ppm]
Number | red blood cell | ehite blood cell | packed cell volume | hemoglobin | serum total protein | GOT | GPT | ALP | BUN |
10^4/ mm^3 | /mm^3 | % | g/dl | g/dl | Karmen | Karmen | King-armstrong | mg/dl | |
1 | 626 | 7550 | 42.0 | 13.1 | 6.0 | - | - | - | - |
2 | 608 | 5500 | 41.5 | 13.1 | 5.6 | - | - | - | - |
3 | 591 | 5750 | 42.0 | 13.9 | 5.4 | 72.0 | 27.0 | 35.1 | 19.5 |
4 | 706 | 5150 | 42.5 | 13.4 | 5.5 | 61.0 | 23.0 | 31.7 | 19.5 |
5 | 647 | 7450 | 40.5 | 13.1 | 5.4 | 62.0 | 22.0 | 42.0 | 18.7 |
6 | 543 | 6900 | 41.0 | 12.9 | 5.3 | 107.0 | 37.0 | 24.8 | 27.0 |
7 | 569 | 10200 | 40.0 | 12.6 | 5.1 | 80.5 | 40.0 | 32.8 | 25.9 |
8 | 583 | 7100 | 40.0 | 12.9 | 5.4 | 121.0 | 88.5 | 40.7 | 22.7 |
9 | 623 | 10200 | 40.0 | 13.1 | 5.4 | 65.0 | 27.5 | 37.8 | 24.1 |
10 | 577 | 5750 | 39.0 | 12.8 | 5.0 | 86.0 | 44.0 | 35.0 | 18.7 |
Mean | 607 | 7155 | 40.9 | 13.1 | 5.4 | 81.8 | 38.6 | 35.0 | 22.0 |
S.D. | 44 | 1719 | 1.1 | 0.3 | 0.3 | 20.6 | 20.3 | 5.1 | 3.2 |
Table 2: Hematological examination/Biochemical examination [300 ppm]
Number | red blood cell | ehite blood cell | packed cell volume | hemoglobin | serum total protein | GOT | GPT | ALP | BUN |
10^4/ mm^3 | /mm^3 | % | g/dl | g/dl | Karmen | Karmen | King-armstrong | mg/dl | |
11 | 645 | 6000 | 41.0 | 13.2 | 6.0 | 59.0 | 20.0 | 35.3 | 16.9 |
12 | 654 | 7400 | 44.0 | 14.0 | 6.4 | 86.0 | 29.0 | 41.8 | 19.5 |
13 | 698 | 7250 | 43.0 | 13.7 | 5.9 | 59.5 | 22.0 | 43.6 | 17.0 |
14 | 546 | 4900 | 43.5 | 12.9 | 5.0 | 70.0 | 20.0 | 31.7 | 18.7 |
15 | 581 | 5450 | 40.5 | 12.9 | 5.4 | 62.0 | 18.0 | 42.0 | 21.4 |
16 | 618 | 7750 | 40.5 | 13.1 | 5.4 | 75.0 | 31.0 | 21.9 | 22.5 |
17 | 596 | 7450 | 40.0 | 13.3 | 5.4 | - | - | - | - |
18 | 614 | 9250 | 42.5 | 13.3 | 5.4 | 81.5 | 37.0 | 33.0 | 16.5 |
19 | 584 | 7050 | 38.5 | 12.6 | 5.0 | 66.0 | 30.5 | 36.3 | 20.8 |
20 | 611 | 8750 | 39.5 | 13.1 | 5.0 | 63.0 | 26.0 | 32.8 | 18.7 |
Mean | 615 | 7125 | 41.3 | 13.2 | 5.5 | 69.1 | 25.9 | 35.4 | 19.1 |
S.D. | 41 | 1295 | 1.7 | 0.4 | 0.5 | 9.2 | 6.0 | 6.3 | 2.0 |
Table 3: Hematological examination/Biochemical examination [100 ppm]
Number | red blood cell | ehite blood cell | packed cell volume | hemoglobin | serum total protein | GOT | GPT | ALP | BUN |
10^4/ mm^3 | /mm^3 | % | g/dl | g/dl | Karmen | Karmen | King-armstrong | mg/dl | |
21 | 738 | 6900 | 42.5 | 13.8 | 6.0 | 68.0 | 20.0 | 41.8 | 22.0 |
22 | 601 | 8700 | 40.5 | 13.2 | 6.0 | 86.0 | 30.0 | 42.7 | 18.2 |
23 | 623 | 8100 | 43.5 | 14.4 | 6.0 | 90.0 | 24.0 | 35.6 | 16.9 |
24 | 632 | 7600 | 41.0 | 14.1 | 5.4 | 67.5 | 20.0 | 31.7 | 14.4 |
25 | 689 | 6700 | 42.5 | 14.0 | 5.4 | 82.5 | 32.0 | 32.6 | 18.7 |
26 | 591 | 8250 | 40.5 | 12.6 | 5.0 | 72.5 | 36.5 | 38.8 | 19.0 |
27 | 599 | 7200 | 38.0 | 12.5 | 5.4 | 66.0 | 34.0 | 36.5 | 20.7 |
28 | 551 | 7950 | 41.0 | 13.1 | 5.3 | 82.5 | 37.5 | 38.4 | 20.1 |
29 | 592 | 6100 | 40.0 | 13.2 | 5.5 | 74.0 | 33.0 | 38.5 | 21.5 |
30 | 642 | 8500 | 40.5 | 13.5 | 5.0 | 59.5 | 30.5 | 32.4 | 14.4 |
Mean | 626 | 7600 | 41.0 | 13.4 | 5.5 | 74.9 | 29.8 | 36.9 | 18.6 |
S.D. | 51 | 808 | 1.5 | 0.6 | 0.4 | 9.4 | 6.0 | 3.7 | 2.6 |
Table 4: Hematological examination/Biochemical examination [control group]
Number | red blood cell | ehite blood cell | packed cell volume | hemoglobin | serum total protein | GOT | GPT | ALP | BUN |
10^4/ mm^3 | /mm^3 | % | g/dl | g/dl | Karmen | Karmen | King-armstrong | mg/dl | |
31 | 692 | 5550 | 40.5 | 13.7 | 5.8 | 53.0 | 25.0 | 23.0 | 16.9 |
32 | 617 | 10850 | 41.5 | 13.5 | 5.7 | 72.0 | 27.0 | 37.5 | 21.9 |
33 | 582 | 9600 | 43.0 | 14.2 | 6.3 | 57.5 | 18.0 | 38.5 | 18.5 |
34 | 614 | 6150 | 41.0 | 13.7 | 5.3 | 59.0 | 21.5 | 36.0 | 18.1 |
35 | 726 | 7450 | 44.0 | 14.4 | 6.0 | 65.0 | 24.5 | 31.5 | 20.0 |
36 | 630 | 7650 | 39.5 | 12.8 | 5.4 | 64.5 | 28.0 | 35.8 | 21.2 |
37 | 662 | 9250 | 40.0 | 13.1 | 5.9 | 69.5 | 35.5 | 36.6 | 15.5 |
38 | 608 | 6500 | 40.0 | 13.2 | 5.2 | 69.0 | 27.0 | 25.7 | 18.5 |
39 | 598 | 8650 | 40.5 | 13.1 | 5.1 | 60.0 | 23.0 | 35.6 | 28.9 |
40 | 686 | 6000 | 39.5 | 13.4 | 5.4 | 57.0 | 23.5 | 30.2 | 14.1 |
Mean | 642 | 7765 | 41.0 | 13.5 | 5.6 | 62.7 | 25.3 | 33.0 | 19.8 |
S.D. | 45 | 1680 | 1.4 | 0.5 | 0.4 | 6.0 | 4.4 | 5.0 | 3.7 |
Table 5: Absolute organ weight/Relative organ weight [500ppm]
Number | Liver | Kidney | Spleen | Brain | Testis | Lung | Adrenal gland | Heart | ||||||||
g | % | g | % | g | % | g | % | g | % | g | % | g | % | g | % | |
1 | 14.978 | 4.243 | 2.819 | 0.799 | 0.948 | 0.269 | 1.906 | 0.540 | 3.148 | 0.892 | 1.596 | 0.452 | 0.049 | 0.014 | 1.145 | 0.324 |
2 | 13.323 | 4.298 | 2.647 | 0.854 | 0.831 | 0.268 | 1.828 | 0.590 | 3.019 | 0.974 | 1.360 | 0.439 | 0.051 | 0.016 | 0.977 | 0.315 |
3 | 13.635 | 4.342 | 2.535 | 0.807 | 0.726 | 0.231 | 1.891 | 0.602 | 3.184 | 1.014 | 1.369 | 0.436 | 0.052 | 0.017 | 1.089 | 0.347 |
4 | 15.046 | 4.559 | 2.673 | 0.810 | 1.016 | 0.308 | 1.863 | 0.565 | 3.182 | 0.964 | 1.489 | 0.451 | 0.056 | 0.017 | 1.248 | 0.378 |
5 | 15.010 | 4.276 | 2.757 | 0.785 | 0.755 | 0.215 | 1.897 | 0.540 | 2.932 | 0.835 | 1.622 | 0.462 | 0.050 | 0.014 | 1.167 | 0.332 |
6 | 16.275 | 4.690 | 2.502 | 0.721 | 0.970 | 0.280 | 1.833 | 0.528 | 2.927 | 0.844 | 1.550 | 0.447 | 0.051 | 0.015 | 1.062 | 0.306 |
7 | 15.366 | 4.428 | 2.820 | 0.813 | 0.902 | 0.260 | 1.852 | 0.534 | 3.221 | 0.928 | 1.578 | 0.455 | 0.062 | 0.018 | 0.991 | 0.286 |
8 | 16.919 | 4.674 | 2.779 | 0.768 | 1.154 | 0.319 | 1.881 | 0.520 | 3.156 | 0.872 | 1.706 | 0.471 | 0.060 | 0.017 | 0.982 | 0.271 |
9 | 15.783 | 4.409 | 2.732 | 0.763 | 0.846 | 0.236 | 1.861 | 0.520 | 3.001 | 0.838 | 1.515 | 0.423 | 0.051 | 0.014 | 1.127 | 0.315 |
10 | 14.917 | 4.400 | 2.874 | 0.848 | 0.978 | 0.288 | 1.907 | 0.563 | 3.226 | 0.952 | 1.635 | 0.482 | 0.056 | 0.017 | 1.044 | 0.308 |
Arithmetic Mean | 15.125 | 4.432 | 2.714 | 0.797 | 0.913 | 0.267 | 1.872 | 0.550 | 3.100 | 0.911 | 1.542 | 0.542 | 0.054 | 0.016 | 1.083 | 0.318 |
S.D | 1.029 | 0.151 | 0.117 | 0.038 | 0.122 | 0.032 | 0.027 | 0.027 | 0.111 | 0.061 | 0.106 | 0.016 | 0.004 | 0.001 | 0.85 | 0.029 |
g: absolute organ weight
%: relative weight
Table 6: Absolute organ weight/Relative organ weight [300ppm]
Number | Liver | Kidney | Spleen | Brain | Testis | Lung | Adrenal gland | Heart | ||||||||
g | % | g | % | g | % | g | % | g | % | g | % | g | % | g | % | |
11 | 16.442 | 4.480 | 2.719 | 0.741 | 0.817 | 0.226 | 1.919 | 0.523 | 3.095 | 0.843 | 1.565 | 0.426 | 0.064 | 0.017 | 1.072 | 0.292 |
12 | 13.745 | 4.140 | 2.498 | 0.752 | 0.794 | 0.239 | 1.885 | 0.568 | 2.918 | 0.879 | 1.565 | 0.471 | 0.054 | 0.016 | 0.989 | 0.298 |
13 | 13.042 | 4.127 | 2.244 | 0.710 | 0.719 | 0.228 | 1.999 | 0.633 | 3.165 | 1.002 | 1.461 | 0.462 | 0.041 | 0.013 | 0.974 | 0.308 |
14 | 15.517 | 4.346 | 2.739 | 0.767 | 1.037 | 0.290 | 1.917 | 0.537 | 3.059 | 0.857 | 1.396 | 0.391 | 0.058 | 0.016 | 0.997 | 0.279 |
15 | 14.746 | 4.262 | 2.868 | 0.829 | 0.792 | 0.229 | 1.891 | 0.547 | 2.978 | 0.861 | 1.407 | 0.407 | 0.040 | 0.012 | 1.051 | 0.304 |
16 | 15.906 | 4.637 | 2.884 | 0.841 | 0.813 | 0.237 | 1.907 | 0.556 | 3.230 | 0.942 | 1.443 | 0.421 | 0.048 | 0.014 | 1.022 | 0.298 |
17 | 15.012 | 4.377 | 2.975 | 0.867 | 0.952 | 0.278 | 1.915 | 0.558 | 3.450 | 1.006 | 1.610 | 0.469 | 0.054 | 0.016 | 1.073 | 0.313 |
18 | 15.648 | 4.408 | 3.105 | 0.875 | 0.789 | 0.222 | 1.994 | 0.562 | 3.192 | 0.899 | 1.498 | 0.422 | 0.055 | 0.015 | 1.145 | 0.323 |
19 | 15.640 | 4.258 | 2.775 | 0.760 | 0.916 | 0.251 | 1.875 | 0.514 | 2.976 | 0.815 | 1.621 | 0.444 | 0.050 | 0.014 | 1.075 | 0.295 |
20 | 17.861 | 4.651 | 2.696 | 0.702 | 1.123 | 0.292 | 1.892 | 0.493 | 3.378 | 0.880 | 1.713 | 0.446 | 0.055 | 0.014 | 1.129 | 0.294 |
Arithmetic Mean | 15.346 | 4.369 | 2.750 | 0.784 | 0.875 | 0.249 | 1.919 | 0.549 | 3.144 | 0.898 | 1.528 | 0.436 | 0.052 | 0.015 | 1.053 | 0.300 |
S.D | 1.278 | 0.173 | 0.231 | 0.060 | 0.122 | 0.026 | 0.041 | 0.036 | 0.166 | 0.062 | 0.098 | 0.026 | 0.007 | 0.001 | 0.055 | 0.012 |
g: absolute organ weight
%: relative weight
Table 7: Absolute organ weight/Relative organ weight [100ppm]
Number | Liver | Kidney | Spleen | Brain | Testis | Lung | Adrenal gland | Heart | ||||||||
g | % | g | % | g | % | g | % | g | % | g | % | g | % | g | %* | |
21 | 15.747 | 4.845 | 2.528 | 0.778 | 0.984 | 0.303 | 1.897 | 0.584 | 2.819 | 0.867 | 1.513 | 0.466 | 0.044 | 0.014 | 0.997 | 0.3 |
22 | 15.326 | 4.774 | 2.717 | 0.846 | 0.898 | 0.280 | 1.890 | 0.589 | 2.798 | 0.872 | 1.319 | 0.411 | 0.043 | 0.013 | 0.990 | 0.3 |
23 | 16.049 | 4.585 | 2.751 | 0.786 | 0.901 | 0.257 | 1.972 | 0.563 | 2.857 | 0.816 | 1.469 | 0.420 | 0.052 | 0.015 | 1.148 | 0.3 |
24 | 14.356 | 4.044 | 2.491 | 0.702 | 0.904 | 0.255 | 1.763 | 0.479 | 2.729 | 0.769 | 1.446 | 0.407 | 0.061 | 0.017 | 1.046 | 0.2 |
25 | 15.000 | 4.323 | 2.531 | 0.729 | 0.933 | 0.269 | 1.869 | 0.539 | 3.490 | 1.006 | 1.321 | 0.381 | 0.060 | 0.017 | 1.053 | 0.3 |
26 | 14.867 | 4.334 | 2.679 | 0.781 | 0.929 | 0.271 | 1.860 | 0.542 | 3.218 | 0.938 | 1.418 | 0.413 | 0.051 | 0.015 | 1.128 | 0.3 |
27 | 15.757 | 4.414 | 2.631 | 0.737 | 0.768 | 0.215 | 1.920 | 0.538 | 3.042 | 0.852 | 1.549 | 0.434 | 0.050 | 0.014 | 1.044 | 0.2 |
28 | 14.777 | 4.234 | 2.395 | 0.686 | 0.663 | 0.190 | 1.859 | 0.533 | 2.997 | 0.859 | 1.411 | 0.404 | 0.052 | 0.015 | 1.006 | 0.2 |
29 | 16.977 | 4.651 | 2.525 | 0.692 | 0.788 | 0.216 | 1.929 | 0.528 | 3.429 | 0.939 | 1.595 | 0.437 | 0.063 | 0.017 | 1.025 | 0.2 |
30 | 13.903 | 3.972 | 2.876 | 0.822 | 0.921 | 0.263 | 1.988 | 0.568 | 2.476 | 0.707 | 1.578 | 0.451 | 0.064 | 0.018 | 1.146 | 0.3 |
Arithmetic Mean | 15.276 | 4.418 | 2.612 | 0.756 | 0.869 | 0.252 | 1.895 | 0.546 | 2.986 | 0.863 | 1.462 | 0.422 | 0.054 | 0.016 | 1.058 | 0.3 |
S.D | 0.846 | 0.279 | 0.137 | 0.052 | 0.093 | 0.033 | 0.061 | 0.030 | 0.302 | 0.082 | 0.093 | 0.024 | 0.007 | 0.002 | 0.058 | 0.01 |
g: absolute organ weight
%: relative weight
Cause there are no abnormality findings in the study on the heart, this data gap is negligible and therefore does not lead to a deterioration of the results of this study
Table 8: Absolute organ weight/Relative organ weight [control group]
Number | Liver | Kidney | Spleen | Brain | Testis | Lung | Adrenal gland | Heart | ||||||||
g | % | g | % | g | % | g | % | g | % | g | % | g | % | g | % | |
31 | 15.710 | 4.540 | 2.412 | 0.697 | 0.722 | 0.209 | 1.945 | 0.562 | 3.194 | 0.923 | 1.501 | 0.434 | 0.049 | 0.014 | 1.043 | 0.301 |
32 | 16.429 | 4.861 | 2.327 | 0.688 | 1.102 | 0.328 | 1.795 | 0.531 | 1.075 | 0.318 | 1.656 | 0.490 | 0.049 | 0.014 | 1.027 | 0.304 |
33 | 16.141 | 4.521 | 2.386 | 0.668 | 1.049 | 0.294 | 1.840 | 0.515 | 3.151 | 0.883 | 1.534 | 0.430 | 0.063 | 0.018 | 1.014 | 0.284 |
34 | 12.400 | 3.792 | 2.092 | 0.640 | 0.714 | 0.218 | 1.773 | 0.542 | 2.127 | 0.650 | 1.411 | 0.431 | 0.050 | 0.015 | 0.798 | 0.299 |
35 | 15.653 | 4.397 | 2.343 | 0.658 | 0.889 | 0.250 | 1.835 | 0.515 | 3.209 | 0.901 | 1.479 | 0.415 | 0.053 | 0.015 | 1.121 | 0.315 |
36 | 14.892 | 4.231 | 2.470 | 0.702 | 0.815 | 0.232 | 2.005 | 0.570 | 3.029 | 0.861 | 1.574 | 0.447 | 0.057 | 0.016 | 1.049 | 0.298 |
37 | 15.694 | 4.014 | 2.762 | 0.706 | 0.921 | 0.236 | 1.852 | 0.474 | 2.662 | 0.681 | 1.630 | 0.417 | 0.049 | 0.013 | 1.061 | 0.271 |
38 | 12.952 | 3.669 | 2.391 | 0.677 | 0.800 | 0.227 | 1.986 | 0.563 | 3.227 | 0.914 | 1.479 | 0.419 | 0.047 | 0.013 | 1.200 | 0.340 |
39 | 14.818 | 4.071 | 2.747 | 0.755 | 0.900 | 0.247 | 1.922 | 0.528 | 3.244 | 0.891 | 1.633 | 0.449 | 0.046 | 0.013 | 1.139 | 0.313 |
40 | 14.639 | 4.000 | 2.449 | 0.669 | 1.013 | 0.277 | 1.877 | 0.513 | 3.329 | 0.910 | 1.544 | 0.422 | 0.053 | 0.014 | 1.068 | 0.292 |
Arithmetic Mean | 14.933 | 4.210 | 2.438 | 0.686 | 0.893 | 0.252 | 1.883 | 0.531 | 2.825 | 0.793 | 1.544 | 0.435 | 0.052 | 0.015 | 1.052 | 0.302 |
S.D | 1.259 | 0.351 | 0.187 | 0.030 | 0.126 | 0.035 | 0.075 | 0.028 | 0.678 | 0.184 | 0.075 | 0.021 | 0.005 | 0.002 | 0.101 | 0.018 |
g: absolute organ weight
%: relative weight
Applicant's summary and conclusion
- Conclusions:
- The male rats were exposed to 500, 300 and 100 ppm 3-methyl-3-methoxybutanol by inhalation for 4 hours a day, 5 days a week (total 20 times of inhalation. Although no severe effect in the animals was noted, the serum transaminase (GOT) activity and absolute and relative kidney weights of the experimental groups were significantly higher than those of control group. As the results, it was considered that liver and kidney were slightly affected by MMB.
- Executive summary:
Inhalation exposure to MMB at the concentrations of 500, 300 and 100 ppm for 4 hours a day, 5 days a week (total 20 times of inhalation) produced following findings in male rats.
1) GOT activity in 500 ppm and 100 ppm exposure groups was significantly higher than that of control group.
2) The Absolute and relative kidney weights in all exposure groups were significantly higher than that of control group. However no abnormal findings were noted in liver histopathologically and except for GOT activity, liver function tests showed no abnormalities. Regarding kidney, there was no significant difference between each experimental group and control group in each functional examination and no toxicological relevant change was noted in histopathological examinations.
These results were summarized as follows.
It is considered that under this experiment condition, although MMB exposure slightly affected liver and kidney, MMB exposure caused no severe effect in organs. Therefore, it is necessary to pay attention enough if there is a possibility to inhale MMB for a long time. The chemical’s action to the living body may be different according to the animal species. It would be desirable to examine the influence of this material to the living body further in the greater detail by long term experiment.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live2